As we enter 2025, the MedTech industry is poised for significant transformation. Two key areas expected to drive growth are robotic surgery and artificial intelligence (AI), which are garnering increasing attention from investors, clinicians, and innovators. However, while these technologies hold immense promise, a critical challenge remains: the absence of separate reimbursement pathways, such as new codes or distinct payment categories. Instead, these innovations must navigate existing reimbursement frameworks, making market access and evidence generation essential for their adoption. Demonstrating their value through proof, rather than a mere proposition, is paramount. Let’s examine these trends and explore the reimbursement and market access insights shaping their trajectory in 2025 and beyond.

Securing commercial insurance coverage for medical technology often hinges on one critical question: How much evidence is necessary to satisfy payer requirements? While “it depends” is a common, albeit frustrating, response, this article seeks to clarify this ambiguity and explain the factors driving the evidence requirements for the creation of medical policies.

For the fifth consecutive year, PRIA Healthcare is honored to sponsor LSI’s Emerging MedTech Summit – a premier gathering of visionaries dedicated to advancing healthcare innovation. LSI’s commitment to accelerate MedTech investment and commercialization resonates deeply with our own. At PRIA, we partner with innovators, investors, and industry leaders to bridge the gap between groundbreaking technology and real-world patient access. By navigating the complexities of market access, reimbursement, and commercialization, we help ensure that life-changing medical advancements reach the patients who need them most.

Innovating in today’s medical device industry is insanely hard. The majority of the MedTech industry consists of small companies – over 80% have fewer than 50 employees. The funding market has gotten significantly tougher in recent years. Most MedTech entrepreneurs are first timers, navigating unknowns with a long list of questions. Few go on to launch a second company, making veteran co-founders a rare breed.

PRIA Healthcare is proud to announce its partnership with MedTech Innovator, the world’s largest accelerator for medical device, digital health, and diagnostic companies. This collaboration brings together two organizations with synergistic missions. MedTech Innovator is dedicated to improving patients’ lives by accelerating the growth of companies transforming healthcare worldwide. PRIA Healthcare, a leading full-spectrum reimbursement services and market access firm, is committed to accelerating the adoption of healthcare innovation by advocating for consistent and reliable reimbursement. Together, this partnership will empower MedTech companies with the tools and guidance necessary to navigate complex commercialization challenges.

Join us for the MedTech in 2025 webinar

As we enter 2025, the MedTech industry is poised for significant transformation. Two key areas expected to drive growth are robotic surgery and artificial intelligence (AI), which are garnering increasing attention from investors, clinicians, and innovators. However, while these technologies hold immense promise, a critical challenge remains: the absence of separate reimbursement pathways, such as new codes or distinct payment categories. Instead, these innovations must navigate existing reimbursement frameworks, making market access and evidence generation essential for their adoption. Demonstrating their value through proof, rather than a mere proposition, is paramount. Let’s examine these trends and explore the reimbursement and market access insights shaping their trajectory in 2025 and beyond.

PRIA’s Ryan Nolan recently hosted an insightful webinar on overcoming the adoption challenges of groundbreaking AI innovations in MedTech. He was joined by industry experts Stacey Stevens, Laurel Sweeney, and J. David Giese, who shared strategies and real-world experiences in the complexities of implementing AI solutions in healthcare.

PRIA Healthcare, a leader in innovative patient access and reimbursement services, is proud to announce the acquisition of Argenta Advisors, a renowned consulting firm specializing in market access and reimbursement strategy. The acquisition, finalized on September 1, 2024, represents a significant step in PRIA Healthcare’s mission to enhance its comprehensive suite of services and further support medical technology companies in navigating the complexities of the healthcare landscape.